161 related articles for article (PubMed ID: 16489098)
1. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
Langsenlehner U; Yazdani-Biuki B; Eder T; Renner W; Wascher TC; Paulweber B; Weitzer W; Samonigg H; Krippl P
Clin Cancer Res; 2006 Feb; 12(4):1392-4. PubMed ID: 16489098
[TBL] [Abstract][Full Text] [Related]
2. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
Li F; Ren GS; Li HY; Wang XY; Chen L; Li J
Clin Oncol (R Coll Radiol); 2009 May; 21(4):302-5. PubMed ID: 19138835
[TBL] [Abstract][Full Text] [Related]
3. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
4. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
[TBL] [Abstract][Full Text] [Related]
5. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
6. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
[TBL] [Abstract][Full Text] [Related]
7. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
8. The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Wolf G; Wascher TC; Paulweber B; Samonigg H
Cancer Lett; 2004 Mar; 206(1):59-62. PubMed ID: 15019160
[TBL] [Abstract][Full Text] [Related]
9. Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children.
Chan IH; Tang NL; Leung TF; Ma SL; Zhang YP; Wong GW; Wong CK; Lam CW
Allergy; 2007 Jul; 62(7):802-9. PubMed ID: 17573729
[TBL] [Abstract][Full Text] [Related]
10. Association of interleukin-10 gene variation with breast cancer prognosis.
Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
[TBL] [Abstract][Full Text] [Related]
11. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Naidu R; Har YC; Taib NA
J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
[TBL] [Abstract][Full Text] [Related]
12. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
[TBL] [Abstract][Full Text] [Related]
14. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
[TBL] [Abstract][Full Text] [Related]
15. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.
Colaizzo D; Fofi L; Tiscia G; Guglielmi R; Cocomazzi N; Prencipe M; Margaglione M; Toni D
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):93-6. PubMed ID: 16479190
[TBL] [Abstract][Full Text] [Related]
16. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.
Blasiak J; Przybyłowska K; Czechowska A; Zadrozny M; Pertyński T; Rykała J; Kołacińska A; Morawiec Z; Drzewoski J
Acta Biochim Pol; 2003; 50(1):249-53. PubMed ID: 12673366
[TBL] [Abstract][Full Text] [Related]
18. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
19. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
[TBL] [Abstract][Full Text] [Related]
20. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
Zúbor P; Vojvodová A; Danko J; Kajo K; Szunyogh N; Lasabová Z; Biringer K; Visnovský J; Dókus K; Galajda P; Plank L
Neoplasma; 2006; 53(1):49-55. PubMed ID: 16416013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
